Test Price
450 AED✅ Home Collection Available
Immunophenotyping by Flow Cytometry CD14 Test in UAE – 450 AED
Executive Summary & Core Metrics
Executive Summary – UAE Premier Service
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Immunophenotyping by Flow Cytometry CD14 test is a precise diagnostic tool to evaluate CD14 antigen expression on monocytes and myeloid cells, aiding in the classification and monitoring of hematological malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndromes.
Our Test vs. Closest Alternative
| Feature | Our CD14 Flow Cytometry | Standard CBC + Manual Differential |
|---|---|---|
| Methodology | Multicolor Flow Cytometry (CD14 monoclonal antibody panel) | Automated cell counter with microscopic review |
| Diagnostic Precision | >99.9% sensitivity for monocytic lineage | Limited to blast percentage; no immunophenotype |
| Turnaround Time | Same day (sample by 9 AM) | 2–4 hours (without lineage classification) |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology (DHA Registration ID: 61713011), shares: “Understanding your immunophenotype results is a critical step in your personalized cancer care journey. I am here to correlate these laboratory findings with your clinical picture, ensuring no detail is overlooked. Please remember that these numbers are only part of your story; always discuss them in the context of your complete health.”
Medication Advisory
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Absolute contraindication: Known severe allergy to EDTA or heparin anticoagulants (if skin testing confirms).
- Relative contraindication: Severe thrombocytopenia (<20,000/µL) – bone marrow procedure may be delayed.
- ER Red Flags (seek immediate medical attention): Uncontrolled bleeding from procedure site, fever >38.5°C, intense pain unrelieved by simple analgesia, or signs of infection (redness, swelling, pus).
- Patients with active systemic infection or hemodynamic instability should postpone elective sampling until stabilized.
Patient FAQ & Clinical Guidance
1. What is the purpose of a CD14 immunophenotyping test?
CD14 flow cytometry quantifies CD14-positive cells, enabling accurate diagnosis and monitoring of acute myeloid leukemia. This test detects the monocytic differentiation pathway, allowing hematologists to classify AML subtypes, distinguish myelomonocytic leukemias, and track minimal residual disease after treatment. It provides critical information that standard morphology alone cannot offer.
2. How should I prepare for the CD14 immunophenotyping test?
No special preparation; continue prescribed drugs and follow your doctor's specific guidance for sample collection. Blood or bone marrow is collected by trained professionals using strict aseptic technique. For bone marrow aspiration, you may be asked to sign an informed consent; local anesthesia is used. Transportation of the sample is immediate at 18–22°C—never refrigerate or freeze. Please ensure all clinical details and exact timing are documented on the test request form.
3. What do the CD14 results mean?
CD14 positivity indicates monocytic differentiation, aiding subtype classification of acute myeloid leukemia and therapy monitoring. A high percentage of CD14+ blasts often correlates with monocytic or myelomonocytic leukemia (AML-M4/M5 according to FAB classification). Results are interpreted together with other markers (e.g., CD13, CD33, CD34) and clinical findings. Your consultant will explain how these numbers influence your treatment plan and prognosis.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Governance: All personal health data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Our facility operates under DHA License No. 1143 (Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE). We adhere to strict confidentiality protocols, secure data storage, and patient consent requirements. Your privacy is paramount.
Clinical & Logistical Metadata
| Test Name | Immunophenotyping by Flow Cytometry CD14 |
| Price (AED) | 450 AED |
| Turnaround Time | Same day (sample collected by 9:00 AM at hospital) |
| Sample Type / Matrix | Peripheral Blood or Bone Marrow (Hospital Extraction Only) |
| Methodology Used | Multicolor Flow Cytometry (CD14 monoclonal antibody panel) |
| ICD-10-CM Code | C92.0, C92.5, C93.9 |
| LOINC Code | 9395-7 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians